A practice quit model to test early efficacy of medications for alcohol use disorder in a randomized clinical trial

ConclusionsThis study reports mostly null findings, which challenges us to decompose its nuanced design to consider model refinements. Possible changes to the model include considering the requirement for intrinsic motivation for change, including a longer practice quit period, encompassing the medication administration timeframe in the practice quit period, increasing the required sample size for signal detection, and examining a post COVID-19 pandemic cohort.
Source: Psychopharmacology - Category: Psychiatry Source Type: research